What Happened to Olaplex

On a rainy night in Beverly Hills in 2014, Dean Christal handed celebrity colorist Tracey Cunningham a small bottle of clear liquid. The next day, she used it on Gwyneth Paltrow and Jennifer Lopez. She told Christal she would never color hair without it again. Within months, every stylist in Los Angeles wanted it. Within two years, Olaplex had become the fastest-growing brand in professional hair care. Within seven years, it was worth $15 billion on the Nasdaq. And within four years after that, on March 26, 2026, Henkel bought the whole thing for $1.4 billion. That is a 90% collapse in value, and every founder building a consumer brand should understand why it happened.

Olaplex is a bond-building hair care brand that repairs broken disulfide bonds in hair during and after chemical treatments, originally developed by chemists at UC Santa Barbara and launched through professional salons before expanding to mass retail.

Last updated: March 2026

How Olaplex became a $15 billion company

Olaplex started in a garage. Dean Christal, who grew up in the beauty industry (his mother ran a salon out of their house, his father distributed beauty products from 26 stores), had been doing stem cell research when he connected with Dr. Craig Hawker and Dr. Eric Pressly at UC Santa Barbara. Pressly had developed a molecule that could cross-link broken sulfur hydrogen bonds in hair during chemical processing. Christal recognized it immediately as something the salon industry had never seen.

They launched Olaplex on June 24, 2014, with a single product sold exclusively to salons. The strategy was deliberate and, at the time, brilliant. Stylists became unpaid evangelists because the product genuinely worked: clients could get aggressive color treatments without the damage that normally came with bleaching. The salon channel created scarcity and perceived expertise. You couldn’t buy Olaplex at Target. You couldn’t order it on Amazon. You had to sit in a salon chair, and your stylist had to choose to use it. That friction was the product’s greatest marketing asset.

Revenue grew without a traditional marketing budget. By 2018, Olaplex was generating over $100 million in annual sales with fewer than 30 employees. Profit margins were extraordinary because the professional channel commands premium pricing and the product’s formulation costs were relatively low. It was the kind of brand that private equity dreams about: high margins, cult loyalty, and a clear path to scale.

By 2019, the brand was doing so well that Advent International acquired Olaplex for $1.4 billion. Under new CEO JuE Wong, the company prepared for an IPO. When it went public on September 30, 2021, Olaplex priced at $21 per share and immediately surged. At peak, the company was valued at $15.88 billion. The stock hit an all-time high of $29.41 on January 3, 2022.

For context, that is a brand built on a single product line being valued higher than established beauty conglomerates with dozens of brands. The market was pricing in hypergrowth that would need to continue for years.

Why did Olaplex stock crash?

Olaplex stock crashed because three problems hit at the same time, and none of them had a quick fix.

Problem one: the distribution expansion backfired. After the IPO, Olaplex pushed aggressively into retail. The products that used to require a salon visit showed up at Sephora, Ulta, and eventually Amazon. The move generated short-term revenue, but it destroyed the exclusivity that made stylists recommend the brand. When your “professional-grade” product sits next to $12 conditioners on a shelf, the premium positioning erodes. Salon professionals, the original evangelists, felt betrayed and started recommending alternatives.

Problem two: the lawsuit. In February 2023, 28 women sued Olaplex in California, alleging its products caused hair loss, blisters, and scalp damage. The lawsuit specifically targeted lilial, a chemical in Olaplex No. 3 that the EU had banned from cosmetics in March 2022 due to fertility risks in animal studies. The case was eventually dismissed (the class action was denied in July 2023 and individual claims were dropped), but the damage was done. Headlines about hair loss spread across social media faster than any court ruling could correct. Consumer trust, once lost, is almost impossible to rebuild through legal victories.

Problem three: competitors filled the gap. While Olaplex was dealing with lawsuits and distribution chaos, competitors moved in. K18 launched a leave-in treatment that stylists embraced as the “new Olaplex.” Redken, backed by L’Oreal’s distribution muscle, introduced bond-building alternatives. Ouai targeted the same demographic with sleeker marketing. The product moat that seemed unbreakable in 2019 had been eroded from every direction by 2024.

The numbers tell the story clearly. In fiscal year 2023, Olaplex’s US net sales dropped 47.8% compared to the previous year. Net income sank 74.8%. The stock, which opened at $25 on IPO day and peaked at $29.41 in January 2022, was trading at just $1.30 per share by early 2026. The company that was once valued more than Coty went from Wall Street darling to a turnaround case in under three years.

What does the Henkel acquisition mean?

On March 26, 2026, Henkel announced it would acquire Olaplex for $1.4 billion at $2.06 per share, a 55% premium over the closing price but a fraction of the company’s peak valuation. The deal was approved unanimously by Olaplex’s board. Advent International, which still held roughly 75% of voting shares, approved the transaction by written consent, meaning no shareholder vote was needed.

The irony is hard to miss. Advent bought Olaplex for $1.4 billion in 2019. Seven years later, after an IPO that briefly valued the company at $15 billion, Henkel is buying it for the exact same price. Advent’s entire journey through the public markets, all the dilution, all the management changes, all the reputational damage, netted out to zero.

For Henkel, a German consumer goods company with $23 billion in annual revenue, this is a bargain. Olaplex’s core technology still works. The brand still has name recognition. Henkel’s existing hair care division (Schwarzkopf, got2b) gives it distribution infrastructure and salon relationships that Olaplex lost. The deal is expected to close in the second half of 2026, after which Olaplex will be delisted from the Nasdaq.

What can founders learn from Olaplex?

Olaplex is a case study that every founder building a consumer brand needs to read carefully. The company did not fail because of a bad product. The product still works. It failed because of a series of strategic decisions that traded long-term brand equity for short-term revenue.

Distribution is strategy, not just logistics. Olaplex’s salon-only model was not a limitation. It was the entire brand. Professional exclusivity created word-of-mouth that no marketing budget could replicate. The moment Olaplex showed up on Amazon, it became just another hair product. LYS Beauty founder Tisha Thompson took the opposite approach: she went to Sephora from day one, but that was always the plan and the brand was built for retail. Olaplex was built for salons and forced into retail. The mismatch showed.

Product moats are not permanent. Olaplex’s bond-building chemistry was genuinely novel in 2014. By 2023, multiple competitors had reverse-engineered comparable products. Patents help, but in beauty, efficacy is subjective and switching costs are near zero. If your competitive advantage is a single technology, you need to be innovating constantly to stay ahead. Olaplex added new SKUs but never recaptured the “nothing else does this” perception of its early years.

Reputation risk is asymmetric. The hair loss lawsuit was dismissed. Olaplex won in court. It did not matter. The headlines traveled faster and further than the court documents. In consumer brands, perception is reality, and negative perception compounds. The same forces that concentrate capital in a few winners also concentrate reputational damage in a few losers. One viral lawsuit can undo a decade of brand building.

Going public changes everything. As a private company, Olaplex could optimize for long-term brand health. As a public company, it had quarterly earnings calls, analyst expectations, and a stock price that demanded growth every 90 days. The pressure to expand distribution, enter new channels, and show revenue growth led directly to the decisions that undermined the brand. Not every company belongs on the public markets. Quince’s founders have built a multi-billion-dollar DTC brand without going public, maintaining control over distribution decisions that a public board might have overruled.

Private equity timelines and brand timelines don’t always align. Advent bought Olaplex, took it public within two years, and the stock started falling almost immediately after IPO. Private equity firms optimize for exit. Brand building optimizes for decades. When the PE clock and the brand clock diverge, the brand usually loses.

Is Olaplex going out of business?

No. Olaplex is not going out of business. The Henkel acquisition is not a liquidation; it is a buyout by a company with the resources and distribution relationships to potentially rebuild the brand. Henkel’s existing salon relationships through Schwarzkopf could restore some of the professional credibility Olaplex lost. The bond-building technology at the core of Olaplex’s product line remains scientifically sound.

What is ending is Olaplex as a publicly traded company. After the acquisition closes, the ticker OLPX will be delisted from the Nasdaq. For consumers, products will likely remain available through existing retail channels. For employees, Henkel has indicated it plans to invest in Olaplex’s innovation and growth, though specific retention plans have not been disclosed.

The bigger question is whether Henkel can do what Olaplex’s own management could not: restore premium positioning while maintaining the retail distribution that now accounts for most of the brand’s revenue. That is a hard needle to thread, and the answer will take years to become clear.

Olaplex’s journey from a garage in Santa Barbara to a $15 billion IPO to a $1.4 billion acquisition is a story about what happens when a genuinely great product meets the wrong growth strategy. The founders built something real. The private equity playbook optimized for speed. And the public markets punished the resulting contradictions. For every founder sitting on a product people love, the question is not whether to grow but how, and Olaplex is the most expensive reminder in recent beauty history that the answer matters.